AUG 06, 2019 6:17 PM PDT

Relieving a Mechanism That Could Underlie as Many as 20 Rare Disorders

WRITTEN BY: Carmen Leitch

Proteins are critical to organisms; they carry out necessary functions and form essential structures. Coding sequences in the genome are used by cells to create strings of amino acids, which have to be properly folded into a three-dimensional structure to form proteins. Problems with protein structure can lead to various physiological problems and disease.

Misfolded MUC1-fs protein (green) builds up in the kidneys of a mouse model of MUC1 kidney disease. / Credit: Dvela-Levitt M, et al. Cell. 2019

Toxic proteinopathies are a group of inherited diseases that are caused when improperly folded proteins accumulate in cells. Now researchers have learned more about a mechanism that may be causing several of these disorders - a dysfunction in a process called the secretory pathway, which sends proteins for disposal, or to the cell surface. Scientists from the Broad Institute of MIT and Harvard and Brigham and Women's Hospital (BWH) have reported these findings in Cell.

The researchers were investigating MUC1 kidney disease (MKD), a rare kidney disorder caused by a mutation in the MUC1 gene, which creates a misfolded MUC1 protein that accumulates in kidney cells. The cell doesn’t eliminate the aberrant protein because of a sort of secretory pathway traffic jam. A compound, BRD4780, could alleviate the problem.

"What blew my mind is that, in the process of studying the mechanism behind MKD, we have uncovered fascinating new biology about how cells handle misfolded proteins, and these key insights may help us address several devastating diseases," noted study senior author Anna Greka, director of the Broad's Kidney Disease Initiative (KDI), who also has appointments at Harvard Medical School and BWH. "Our team is working around the clock to translate these discoveries into a new therapy we can bring to patients as quickly as possible."

The compound rescued the pathway defect in a variety of models, including kidney organoids (mini-kidney models), human kidney cells, and an animal MKD model. Researchers can now use BRD4780 to development treatments for MKD and other toxic proteinopathies. There are no therapies available for these disorders right now.

The scientists also found how it was working; BRD4780 binds to a receptor called TMED9, not the misfolded protein. In the MKD model, the TMED9 receptor was found to be trapping the aberrant protein, which prevented it from moving to the lysosome, where it would normally be degraded. The improperly folded protein was then accumulating and causing problems for kidney cells, which eventually die because of it. When BRD4780 attached to TMED9, however, the receptor released the protein, and the cell could then degrade it.

When the team blocked TMED9 expression using CRISPR, they saw the same result.

"This is completely new biology," Greka said. "We did not know that a cargo receptor like TMED9 could block and ultimately interfere with the destruction of a misfolded protein. And the question became, is the same biology at work in other conditions caused by a buildup of misfolded proteins?"

Over fifty diseases are toxic proteinopathies. The researchers suggested that BRD4780 might be of therapeutic use for twenty diseases in which misfolded proteins get trapped.

"Many of these disorders may tie back to the same mechanism," Greka explained. "Our next step is to develop a deeper understanding of cargo receptors, why they stop misfolded proteins from being eliminated as they should and figure out exactly how to develop drugs to counter them."


Sources: AAAS/Eurekalert! Via Broad Institute, Cell

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
JAN 25, 2020
Cell & Molecular Biology
JAN 25, 2020
Understanding How Skin Regeneration is Controlled
Our skin is a critical protective barrier, and has to constantly replenish and repair itself after damage or just normal wear and tear....
JAN 25, 2020
Cell & Molecular Biology
JAN 25, 2020
Brains are More Symmetrical in People With Autism
The two halves of the brain and typically assymterical, but that may be less true for individuals with autism spectrum disorder....
JAN 25, 2020
Cell & Molecular Biology
JAN 25, 2020
Insulin Can Help Stop the Spread of Viruses by Triggering a Mosquito Immune Pathway
There are no treatments for dengue, West Nile and Zika viruses, but researchers may have found a way to reduce the chance that they will spread....
JAN 25, 2020
Immunology
JAN 25, 2020
Playing "Tag" with the Immune System
Human cells employ an intricate tagging system to manage protein activity in the body. By “tagging” a protein with a certain modification, cell...
JAN 25, 2020
Genetics & Genomics
JAN 25, 2020
Engineering a Better Viral Delivery System for Gene Therapy
To send gene therapy to diseased cells, scientists have turned to adeno-associated viruses (AAVs) to act as a delivery system....
JAN 25, 2020
Cell & Molecular Biology
JAN 25, 2020
Newly IDed Biomarker Can Predict Compulsive Drinking
Lots of people drink alcohol, but not everyone develops a drinking problem. Researchers are starting to learn more about why that is....
Loading Comments...